A detailed history of Morgan Stanley transactions in Novo Nordisk A S stock. As of the latest transaction made, Morgan Stanley holds 12,011,853 shares of NVO stock, worth $1.71 Billion. This represents 0.13% of its overall portfolio holdings.

Number of Shares
12,011,853
Previous 10,614,811 13.16%
Holding current value
$1.71 Billion
Previous $1.1 Billion 40.45%
% of portfolio
0.13%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $143 Million - $190 Million
1,397,042 Added 13.16%
12,011,853 $1.54 Billion
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $123 Million - $148 Million
1,399,713 Added 15.19%
10,614,811 $1.1 Billion
Q3 2023

Nov 15, 2023

BUY
$90.94 - $199.54 $412 Million - $903 Million
4,526,199 Added 96.53%
9,215,098 $838 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $13.4 Million - $14.9 Million
86,183 Added 1.87%
4,688,899 $759 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $80.7 Million - $97 Million
-609,682 Reduced 11.7%
4,602,716 $732 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $151 Million - $199 Million
1,472,550 Added 39.37%
5,212,398 $705 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $7.81 Million - $9.58 Million
81,942 Added 2.24%
3,739,848 $373 Million
Q2 2022

Oct 27, 2022

BUY
$103.24 - $121.81 $288 Million - $340 Million
2,792,217 Added 322.54%
3,657,906 $408 Million
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $288 Million - $340 Million
2,792,217 Added 322.54%
3,657,906 $408 Million
Q1 2022

Oct 27, 2022

SELL
$93.1 - $112.54 $260 Million - $314 Million
-2,792,217 Reduced 76.33%
865,689 $96.1 Million
Q1 2022

May 13, 2022

SELL
$93.1 - $112.54 $6.99 Million - $8.45 Million
-75,113 Reduced 7.98%
865,689 $96.1 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $2.17 Million - $2.66 Million
22,677 Added 2.47%
940,802 $105 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $77.5 Million - $97.9 Million
918,125 New
918,125 $88.2 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $322B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.